| EVOTEC SE INH O.N. |
| Deutschland |
| Gesundheit |
| DE0005664809 / 566480 |
| EVT (Frankfurt) |
| FRA:EVT, ETR:EVT, EVT:GR |
| https://www.evotec.com/ |
|
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrate..
>Volltext.. |
| 930.07 Mio. EUR |
| 872.7 Mio. EUR |
| 741.9 Mio. EUR |
| -25.21 Mio. EUR |
| -193.06 Mio. EUR |
| -1.09 EUR |
| 385.83 Mio. EUR |
| 386.28 Mio. EUR |
| - |
| 1.05 |
| -5.48% |
| 6.33% |
| - |
| - |
| - |
| EVOTEC |
| 24.05.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|